These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 16891339)

  • 1. Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
    Shastri M; Alla L; Sabaratnam M
    J Psychopharmacol; 2006 Nov; 20(6):863-7. PubMed ID: 16891339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.
    Deb S; Farmah BK; Arshad E; Deb T; Roy M; Unwin GL
    Res Dev Disabil; 2014 Mar; 35(3):711-25. PubMed ID: 24405794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
    Coley KC; Scipio TM; Ruby C; Lenze EJ; Fabian TJ
    J Psychiatr Pract; 2009 Mar; 15(2):150-3. PubMed ID: 19339850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole prescribing and continuation rates during psychiatric hospitalization.
    Coley KC
    Ann Pharmacother; 2005; 39(7-8):1367-8. PubMed ID: 15956242
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
    Raja M; Azzoni A
    Psychiatr Danub; 2008 Sep; 20(3):323-8. PubMed ID: 18827757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening schizoaffective disorder with aripiprazole.
    Reeves RR; Mack JE
    Am J Psychiatry; 2004 Jul; 161(7):1308. PubMed ID: 15229073
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
    Fujino J; Tanaka H; Taniguchi N; Tabushi K
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):108-9. PubMed ID: 20416032
    [No Abstract]   [Full Text] [Related]  

  • 19. Tardive dystonic symptoms associated with aripiprazole treatment.
    Lim HK; Pae CU; Lee C; Lee CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):589-90. PubMed ID: 18053627
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
    Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.